I will call you paranoid, as am I at times, but once the data is released for COVID all eyes will be on us and what the FDA is going to do with it. It will be too much ignore at this point.

Had a very long talk with Dr Yo the other day and he is still in contact with Dr Bruce Patterson pretty often. Dr Patterson is still very confident in the results for COVID from what I hear even with EQ’s results showing CD6 inhibitor having results on COVID patients. Their drug just further proves that Leronlimab MOA should be great.

If this play out out well for Leronlimab, I’m expecting them to have the ammo (data) they need to be successful.

It does appear the FDA keeps moving the goal post a lot or has in the past. I was talking to Misu about it yesterday and got the break down.

I’m still confused, maybe I need to read the last few post. Do we need the PDUFA date for COVID as well because it was for both HIV and COVID.

Can it be sold or given EUA without the BLA approval? Sorry probably stupid question but I thought this was a totally separate issue with COVID.